Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma

Clin Nucl Med. 2011 Dec;36(12):e194-5. doi: 10.1097/RLU.0b013e3182335e20.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fluorodeoxyglucose F18*
  • Glioblastoma / diagnostic imaging*
  • Humans
  • Male
  • Middle Aged
  • Misonidazole / analogs & derivatives*
  • Positron-Emission Tomography / methods*

Substances

  • fluoromisonidazole
  • Fluorodeoxyglucose F18
  • Misonidazole